A primer set and kit for detecting gene variants in glucose-6-phosphate dehydrogenase (G6PD) deficiency.

By designing multiplex PCR amplification and single-base extension primer sets, combined with an automated nucleic acid mass spectrometer, we have achieved efficient and accurate detection of 21 G6PD deficiency gene variant sites. This solves the problems of incomplete detection sites, complex operation, and high cost in existing technologies, and is suitable for widespread application in hospitals at all levels.

CN122081472APending Publication Date: 2026-05-26LANZHOU BAIYUAN GENE TECH
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202511898039.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-12-16
Publication Date
2026-05-26

Smart Images

  • Figure CN122081472A_ABST
    Figure CN122081472A_ABST
Patent Text Reader

Abstract

This invention discloses a primer set and kit for detecting gene variant sites in glucose-6-phosphate dehydrogenase (G6PD) deficiency, belonging to the field of gene detection technology. The primer set includes multiplex PCR amplification primers shown in SEQ ID NO. 1–14 and single-base extension primers shown in SEQ ID NO. 15–35, capable of simultaneously detecting 21 G6PD pathogenic variant sites (including high-incidence sites in the Chinese population such as c.95A>G and c.202G>A). The kit also includes PCR amplification reaction reagents, SAP enzymatic digestion reaction reagents, extension reaction reagents, desalting resin, and a detection chip. The detection method employs “multiplex PCR amplification → SAP dephosphorylation → single-base extension → nucleic acid mass spectrometry detection,” automatically determining the genotype based on mass-to-charge ratio differences. This invention offers comprehensive site coverage (covering pathogenic mutations in over 99% of Chinese patients), high accuracy (100% consistent with Sanger sequencing results), ease of operation (automatic detection and result analysis), and suitability for small sample sizes. It can be applied to prenatal diagnosis and newborn genetic disease screening, and is suitable for large-scale promotion in hospitals at all levels, providing a reliable tool for rapid and accurate detection of G6PD deficiency.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Primer sequence and kit for detecting glucose-6-phosphate dehydrogenase (G6PD) gene mutation

    CN111118141A

  • Primer set and kit for simultaneously detecting 20 glucose-6-phosphate dehydrogenase deficiency diseases

    CN112442532A